Conference
Earn CE
Free Samples
Magazine
Subscribe
Videos
Solutions Lab
Macro/Op-Ed
Practice
Science & Tech
Money
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Dental Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Caladrius Bio
(NQ:
CLBS
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Sep 14, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
0.4202 (87)
Ask (Size)
0.4210 (29)
Prev. Close
0.4264
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
60,533,064
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why Vintage Wine Estates Shares Tumbled 40%; Here Are 70 Biggest Movers From Yesterday
September 15, 2022
Gainers AMTD Digital Inc. (NYSE: HKD) shares jumped 311.8% to settle at $189.42 on Wednesday as the stock experienced a resurgence in momentum despite a lack of fundamental news.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
September 14, 2022
Via
Benzinga
Performance
More News
Read More
Caladrius Biosciences Stops Enrollment In Mid-Stage Heart Disease Study
May 24, 2022
Via
Benzinga
Caladrius Biosciences To Merge With Privately-Held Cend Therapeutics
April 27, 2022
Via
Benzinga
Why SciSparc Is Trading Higher By 68%, Here Are 48 Stocks Moving In Wednesday's Mid-Day Session
September 14, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
September 02, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
September 02, 2022
Via
InvestorPlace
Why Pagerduty Is Trading Higher By 9%; Here Are 28 Stocks Moving Premarket
September 02, 2022
Via
Benzinga
Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial
August 10, 2022
Via
Benzinga
CALADRIUS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merger of Caladrius Biosciences, Inc. - CLBS
August 03, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
Earnings Outlook For Caladrius Biosciences
August 03, 2022
Via
Benzinga
Caladrius Biosciences's Earnings Outlook
August 03, 2022
Via
Benzinga
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
August 02, 2022
Via
Benzinga
Caladrius Biosciences to Host Second Quarter 2022 Financial Results Conference Call on Thursday, August 4, 2022, at 4:30 p.m. Eastern Time
July 28, 2022
From
Caladrius Biosciences, Inc.
Via
GlobeNewswire
The Daily Biotech Pulse: INmune Bio's Planned Alzheimer's Trial On FDA Hold, Caladrius Stops Enrollment In Heart Disease Study, BiomX Restructures
May 24, 2022
Via
Benzinga
CALADRIUS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Caladrius Biosciences, Inc. - CLBS
May 05, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
74 Biggest Movers From Yesterday
April 29, 2022
Via
Benzinga
48 Stocks Moving In Thursday's Mid-Day Session
April 28, 2022
Via
Benzinga
28 Stocks Moving in Thursday's Pre-Market Session
April 28, 2022
Via
Benzinga
CLBS Stock Alert: Halper Sadeh LLP Is Investigating Whether the Merger of Caladrius Biosciences, Inc. Is Fair to Shareholders
April 27, 2022
From
Halper Sadeh LLP
Via
Business Wire
The Daily Biotech Pulse: Molecular Partners Plunges On Double Bad News, Pfizer/BioNTech Seek Nod For COVID-19 Shot In Kids, Pfizer Invests In Zentalis
April 27, 2022
Via
Benzinga
The Daily Biotech Pulse: Pfizer Reports Positive Ulcerative Colitis Study Data, Novavax COVID Shot Authorized For Adolescents In India, Argenx Stock Sale
March 23, 2022
Via
Benzinga
Recap: Caladrius Biosciences Q4 Earnings
March 23, 2022
Via
Benzinga
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Pfizer Strikes COVID-19 Pill Supply Deal, Argenx Reports Positive Late-Stage Readout
March 22, 2022
Via
Benzinga
Earnings Scheduled For March 22, 2022
March 22, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.